Cargando…
Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker
SIMPLE SUMMARY: Liquid biopsy (LB), encompassing the analysis of circulating tumor material in the blood or urine, has emerged as a powerful tool in the management of prostate cancer. In localized tumors, LB can distinguish between low- and high-grade cancers and can guide the decision to proceed wi...
Autores principales: | Ionescu, Filip, Zhang, Jingsong, Wang, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996910/ https://www.ncbi.nlm.nih.gov/pubmed/35406500 http://dx.doi.org/10.3390/cancers14071728 |
Ejemplares similares
-
Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021) -
Current advances of liquid biopsies in prostate cancer: Molecular biomarkers
por: Alahdal, Murad, et al.
Publicado: (2023) -
Liquid biopsy in gastric cancer: predictive and prognostic biomarkers
por: Zhang, Zihao, et al.
Publicado: (2022) -
Liquid Biopsy Potential Biomarkers in Prostate Cancer
por: Neuhaus, Jochen, et al.
Publicado: (2018) -
Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018)